Verrica Pharmaceuticals (VRCA) announced the presentation of three posters that were presented at the 2025 Winter Clinical Dermatology ...
Verona Pharma (VRNA – Research Report), the Healthcare sector company, was revisited by a Wall Street analyst today. Analyst Ram Selvaraju from ...
India has been traditionally quite strong in the pharma sector, with a low cost of manufacturing (30%–35% lower than in the US and Europe), cost-efficient R&D (about 87% less than in developed markets ...
COPENHAGEN, Denmark, Jan. 06, 2025 (GLOBE NEWSWIRE) -- Ascendis Pharma A/S (Nasdaq: ASND) today announced that company executives will participate in the 43rd Annual J.P. Morgan Healthcare Conference ...
Veeda Group has unveiled a new logo and brand identity—Veeda Lifesciences—reflecting ... with reputable sponsors, including leading global pharma companies.
President-elect Trump’s plan to enact heavy tariffs on certain imports could affect the prices and availability of pharmaceutical drugs in the U.S. Trump has floated 25 percent tariffs on ...
A Reuters analysis of prices for new drugs found that pharmaceutical companies launched new U.S. drugs in 2023 at prices 35% higher than in 2022. The over 250 drug hikes represent an increase from ...
This scenario indicates that 2025 will be a promising year for the pharma sector. A report by Axis Securities last month outlined a positive outlook for the pharmaceutical sector over the next three ...
As may be expected, the United States maintained its position as the leader in pharmaceutical innovation, contributing to nearly half of all drugs in development. However, China’s influence in global ...
Vertex Pharmaceuticals is trying to diversify its product portfolio. One of the programs it's working on aims to treat pain in a few contexts. There's reason to believe that it won't be effective ...
Aerial rendering of planned Vetter pharmaceutical facility at Mount Prospect and Algonquin roads in Des Plaines. Construction of the long-awaited multi-million dollar Vetter Pharma project at ...
The list includes the Pharmaceutical Research and Manufacturers of America, the drug industry’s top U.S. lobbying group, as well as Goldman Sachs, Bank of America, Intuit, General Motors, and Toyota. ...